OncLive® Boosts Strategic Alliance Program with the University of Alabama Birmingham Comprehensive Cancer Center

Share Article

Collaboration to promote cancer center’s advances in cancer research and treatment

News Image
With a vision of eliminating cancer as a major public health problem, the UABCCC’s cutting-edge science continues to be among the nation’s leaders, particularly in the fields of gene therapy, immunotherapy and drug discovery and development.

Past News Releases

RSS

OncLive, a leading digital provider of resources and information to oncology professionals, has expanded its Strategic Alliance Program with the addition of the University of Alabama Birmingham Comprehensive Cancer Center (UABCCC).

In this new partnership, OncLive’s editorial and marketing teams will publicize and promote public awareness of UABCCC’s latest advances in cancer research and treatment. The UABCCC works daily to provide the highest quality of life for patients diagnosed with cancer, while advancing the world’s understanding of cancer and translating this knowledge into prevention, detection, treatment and survivorship.

“With a vision of eliminating cancer as a major public health problem, the UAB Comprehensive Cancer Center’s cutting-edge science continues to be among the nation’s leaders, particularly in the fields of gene therapy, immunotherapy and drug discovery and development,” said Michael Hennessy Jr., president of CURE Media Group. “The organization’s successful advances in cancer research and treatment will add extremely valuable content for oncology professionals to access on OncLive.”

The UABCCC offers a full array of treatment options from multidisciplinary clinics filled with experts from across cancer fields, as well as the latest state-of-the-art technology. Overall, the UABCCC is recognized around the world as a leader in developing innovative monoclonal antibody approaches to cancer therapy. The Center conducts clinical trials using genetically engineered monoclonal antibodies alone or armed with a payload of immunotoxins, chemotherapy drugs or radioactive isotopes to specifically target a broad array of cancers, including breast, gastrointestinal tract, lung, ovary, head and neck, brain tumors and lymphomas.

The UABCCC joins OncLive’s Strategic Alliance Program as the latest of more than 65 partners, including other leading cancer centers, nursing schools and oncology network providers around the country.

About OncLive
A digital platform of resources for practicing oncologists, OncLive.com offers oncology professionals information they can utilize to help provide the best patient care. OncLive is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive, Oncology Nursing News, Oncology Business Management, and more.  Michael J. Hennessy Associates Inc. is a full-service health care communications company offering education, research, medical media, curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE reaches patients, cancer centers and advocacy groups.

About The University of Alabama Birmingham Comprehensive Cancer Center
One of the nation’s leading cancer research and treatment centers, the UAB Comprehensive Cancer Center is the only National Cancer Institute–designated comprehensive cancer center located in a six-state area that includes Alabama, Mississippi, Louisiana, Arkansas, South Carolina and Georgia. The UAB Comprehensive Cancer Center is home to an outstanding faculty of more than 330 physicians and researchers, many of whom are internationally and nationally recognized for their expertise in oncology. The center treats an estimated 5,000 new patients each year.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael J. LaCosta
OncLive
+1 (551) 655-3718
Email >
Visit website